4-Amino-3-Phenylbutyric Acid is a carboxylic or inorganic acid with defined pKₐ value governing its ionisation state across the pH range of biological fluids and pharmaceutical formulations. In pharmaceutical development, 4-Amino-3-Phenylbutyric Acid serves roles including counter-ion selection for API salt formation, pH adjustment and buffering in liquid formulations, and chemical reagent in API synthesis. Toxicological assessment for PDE derivation evaluates local irritancy effects on gastrointestinal mucosa, skin, and respiratory epithelium alongside systemic metabolic consequences of absorbed quantities, with the most sensitive endpoint in the most relevant study forming the POD.
PDE derivation for 4-Amino-3-Phenylbutyric Acid applies the composite uncertainty factor methodology: F1 accounts for interspecies pharmacokinetic and pharmacodynamic differences (default 12 for rat-to-human, refinable with toxicokinetic AUC bridging data), F2 covers intraspecies variability in the human population including sensitive subgroups (de
